Article
Comprehensive characterization of MCL-1 in patients with colorectal cancer: Expression, molecular profiles, and outcomes.
International journal of cancer - 15 Apr 2025
Mittal Pooja, Battaglin Francesca, Baca Yasmine, Xiu Joanne, Farrell Alex, Soni Shivani, Lo Jae Ho, Torres-Gonzalez Lesly, Algaze Sandra, Jayachandran Priya, Ashouri Karam, Wong Alexandra, Zhang Wu, Yu Jian, Zhang Lin, Weinberg Benjamin A, Lou Emil, Shields Anthony F, Goldberg Richard M, Marshall John L, Goel Sanjay, Singh Indrakant K, Lenz Heinz-Josef
Abstract excerpt
Myeloid cell leukemia 1 (MCL-1) is a member of the B-cell lymphoma 2 protein family and has anti-apoptotic functions. Deregulation of MCL-1 has been reported in several cancers, including lung and breast cancer. In the present study, the association of MCL-1 expression with molecular features in colorectal cancer (CRC) has been highlighted. CRC samples from Caris Life Sciences (Phoenix, AZ) were analyzed using...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
